Poly-unsaturated Fatty Acids and Developmental Dyslexia
NCT04287530 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125
Last updated 2024-03-22
Summary
Poly-unsaturated fatty acids (PUFAs) represent a component of lipids that covers a relevant role in human diet and biological functions such as provision of energy, functionality of cell membranes and tissue metabolism. Fatty acids carbon chains can be saturated (with no presence of double bonds) or unsaturated (with one or more double bonds). PUFAs fall into the unsaturated group, and they can be divided into two classes: omega-3 (n-3) and omega-6 (n-6) fatty acids (FAs). PUFAs are relevant components of cellular membranes, phospholipids, and precursors of eicosanoids, which influence neuronal development and functioning, docosahexaenoic acid (DHA) and arachidonic acid (AA) in fact are involved in cell growth, neural signaling, and gene expression. The main natural dietary source for Eicosapentaenoic acid (EPA) and DHA is fish oil. It has also been shown how the Magnocellular system, which includes the retinal ganglion cells, the lateral geniculate nucleus (for the visual system, while the medial geniculate nucleus would be involved for the auditory system) of the thalamus, the posterior parietal cortex, various areas visual of the cortex and part of the cerebellum, is sensitive to the contribution of fatty acids through nutrition. A deficit related to the Magnocellular system, specialized in the processing of stimuli with high temporal frequencies and low spatial frequencies, in both the visual and auditory modalities, has been proposed as one of the causes of Developmental Dyslexia (DD). According to this hypothesis, an alteration at the magnocellular level would affect reading by hampering temporal processing of the visual signal and would reduce the quality of the phonological representations due to imperfect acoustic analysis of the incoming phonemes. It is therefore possible to hypothesize that supplementation of PUFA in dyslexic children would improve the functions of the M-system and thus create better conditions to the remediation of reading difficulties, especially through remediation programs specifically tapping visual attention and rapid processing of visual stimuli. The remediation program currently used at Scientific Institute (IRCCS) Medea, "Tachidino", based on tachistoscopic, hemisphere-specific stimulation and on training of selective visual-spatial attention, has exactly these characteristics.
Hence, the present study aims to test the efficacy of PUFA supplementation before and during treatment with Tachidino.
Conditions
- Dyslexia, Developmental
Interventions
- DIETARY_SUPPLEMENT
-
Poly-unsaturated fatty acids supplementation
Daily supplementation with 6 daily PUFA (Omega-3 and Omega-6) chewable capsules from the beginning (immediately after the pre-testing session) to the end (immediately before the post-testing session) of the observation period, for a total of three months.
- BEHAVIORAL
-
Neuropsychological intervention
Rehabilitation protocol adopted at IRCCS "E. Medea" (remote intervention delivered through the Tachidino platform), delivered during four weeks, starting two months after the pre-testing session.
- DIETARY_SUPPLEMENT
-
Placebo
Daily supplementation with 6 daily Placebo (triglycerides) chewable capsules from the beginning (immediately after the pre-testing session) to the end (immediately before the post-testing session) of the observation period, for a total of three months.
Sponsors & Collaborators
-
University of Milan
collaborator OTHER -
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
collaborator OTHER -
IRCCS Eugenio Medea
lead OTHER
Principal Investigators
-
Maria Luisa Lorusso, PhD · IRCCS Eugenio Medea
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-02
- Primary Completion
- 2024-10-31
- Completion
- 2025-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria
NCT00909012 ·Status: COMPLETED ·Phase: NA
-
Arachidonic Acid Supplementation in Very Preterm Infants
NCT02503020 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD
NCT03542643 ·Status: COMPLETED ·Phase: NA
-
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
NCT00892554 ·Status: COMPLETED ·Phase: NA
-
Docosahexaenoic Acid in the Treatment of Autism
NCT00577447 ·Status: COMPLETED ·Phase: NA
-
Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children
NCT01504633 ·Status: UNKNOWN ·Phase: NA
-
Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) Status
NCT00678067 ·Status: COMPLETED ·Phase: NA
-
The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD
NCT01554462 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory in Infants
NCT02457078 ·Status: UNKNOWN ·Phase: NA
-
Polyunsaturated Fatty Acids in Child Nutrition
NCT01487889 ·Status: COMPLETED ·Phase: NA
-
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
NCT01055119 ·Status: COMPLETED ·Phase: NA
-
Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT02114632 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms
NCT03283579 ·Status: COMPLETED
-
Effect of DHA Supplementation on Cognitive Performance and Growth in Chinese Children
NCT02308930 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Early Life PUFA and R-TFA on AD: A Systematic Review and Meta-analysis
NCT03344783 ·Status: COMPLETED
-
The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood
NCT00615277 ·Status: COMPLETED ·Phase: NA
-
The Effects of DHA on Attention Deficit and Hyperactivity Disorder
NCT01796262 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Polyunsaturated Fatty Acids on the Visual Memory of Children With Attention Deficit Hyperactivity Disorder
NCT03299647 ·Status: UNKNOWN
-
Fish Oil Affects Cognition and ADHD Symptoms in Adults With Autism Spectrum Disorder
NCT04779632 ·Status: COMPLETED ·Phase: NA
-
Memory Improvement With Docosahexaenoic Acid Study (MIDAS)
NCT00278135 ·Status: COMPLETED ·Phase: NA
-
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
NCT00014027 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression
NCT04803071 ·Status: UNKNOWN ·Phase: NA
-
Effect of Mother DHA Supplementation on Term Newborn.
NCT01947426 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fatty Acid Supplementation in Children With ASD (Study 2)
NCT04312932 ·Status: COMPLETED ·Phase: PHASE2